What is MYGN's dilution risk score?

MYGN has a latest available DilutionScore record of 49/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for MYGN, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for MYGN?

DilutionWatch tracks 25 SEC filing types for MYGN including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect MYGN shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For MYGN, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for MYGN tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for MYGN. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

MYGN Dilution Risk Score: 49/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

85

💰 Cash Runway

40

📊 Float Risk

5

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 19%

💰 Capital Raise model 38%

• Active shelf registration ($200M, 53% of market cap)

• Active ATM program with $200M remaining capacity

🔔 Track MYGN — Get forecast alerts →

Market Data

Market Cap$374.96M

Shares Outstanding95.65M

Float85.99M

Cash$115.20M

Debt$319.90M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 145.3% shares (2026Q1 vs prior)

205 institutional holders · 228.54M shares

#1 ORBIMED ADVISORS LLC 125.00M shares

#2 MORGAN STANLEY 10.39M shares

#3 BlackRock, Inc. 8.89M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest8.50M

Days to Cover3.9

% of Float9.9%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

424B3 ATM 2026-03-04

EFFECT EFFECT 2026-03-04

4 INSIDER TRANSACTION 2026-03-02

4 INSIDER TRANSACTION 2026-02-27

S-3 SHELF 2026-02-24

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual MYGN Dilution Snapshot

Myriad Genetics, Inc. (MYGN) has a DilutionScore of 49/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $200.0M.
Stored ATM program remaining capacity: $200.0M.
Recent SEC activity tracked for MYGN: 424B3 on 2026-03-04; EFFECT on 2026-03-04; 4 on 2026-03-02.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.